Table 1 Patients and treatment characteristics
RF, n = 54 | CS, n = 58 | SS, n = 19 | p value | |
|---|---|---|---|---|
Age, years | 62 (53–70) | 67 (55–73) | 62 (55–73) | 0.28 |
Weigh, kga | 76.5 (64–102) | 88 (70–99) | 89.5 (77–102) | 0.33 |
Male | 29 (54) | 37 (64) | 14 (74) | 0.26 |
SOFAb | 6 (3–9) | 10 (8–11) | 8 (6–12) | < 0.01 |
SAPS IIc | 40 (31–60) | 67 (48–78) | 42 (32–61) | < 0.01 |
Comorbidities | ||||
-Art. hypertension | 33 (61) | 34 (60) | 8 (42) | 0.33 |
-Coronary disease | 7 (13) | 40 (70) | 4 (21) | < 0.01 |
-Diabetes mellitus | 11 (20) | 16 (28) | 2 (11) | 0.26 |
-Hyperlipidaemia | 4 (7) | 8 (14) | 5 (26) | 0.11 |
-Kidney injury | 7 (13) | 2 (4) | 1 (5) | 0.16 |
-COPD | 26 (48) | 3 (5) | 4 (21) | < 0.01 |
Duration of hospitalisation, days | 27 (15–40) | 10 (4–36) | 26 (18–67) | < 0.01 |
Duration of ICU stay, days | 20 (8–31) | 7 (3–25) | 20 (17–65) | < 0.01 |
Time on ECMO support, days | 12 (5–19) | 5 (3–8) | 14 (9–25) | < 0.01 |
CPR pre-ECMO | 3 (6) | 38 (66) | 3 (16) | < 0.01 |
Mechanical ventilation time, h | 391 (122–687) | 129 (42–413) | 423 (304–772) | < 0.01 |
Renal replacement therapy | 36 (67) | 45 (78) | 18 (95) | < 0.05 |
Tracheotomy | 33 (61) | 20 (34) | 17 (89) | < 0.01 |
Weaning from ECMO | 35 (65) | 30 (52) | 10 (53) | 0.34 |
Death | 29 (54) | 34 (59) | 11 (58) | 0.86 |
ECMO-treatment before 2014 | 27 (50) | 17 (29) | 1 (5) | < 0.01 |